Onconetix, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
3.79M
on 2026-06-30, from 131 on 2024-03-31 10-Q ↗
Earlier counts are adjusted for four reverse splits; each bar's tip shows the count as filed.
a raise that quarter, at its price
Newest
None
No S-3 or F-3 shelf on file in the last 30 months.
6 of its filings are not read yet.
Warrants
137
Warrants of every class as tagged in the XBRL facts on 2024-09-30, exercise price $38675.00. Adjusted for three reverse splits. 10-Q ↗
Cash
2.3 quarters
$5.9M on 2026-06-30 ÷ $2.6M a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2026-07-28 | Private placement | 37,812 | not read | $30.2M | 8-K ↗ |
| 2025-10-01 | Private placement | 7,813 | not read | $6.3M | 8-K ↗ |
| 2025-09-22 | Private placement | 16,099 | not read | $12.9M | 8-K ↗ |
Also on file: $118K promissory note, 2025-02-12 8-K ↗ · $294K promissory note, 2025-05-16 8-K ↗ · $147K promissory note, 2025-06-05 8-K ↗ · a 1-for-85 reverse split, 2025-06-11 8-K ↗ · $118K promissory note, 2025-08-06 8-K ↗ · $5.1M promissory note, 2025-08-28 8-K ↗ · $5.2M notes, 2025-09-22 8-K ↗ · a 1-for-5 reverse split, 2026-03-23 8-K ↗ · a 1-for-10 reverse split, 2026-05-19 8-K ↗ · up to $5.0M promissory note agreed 2026-09-11 8-K ↗